Adverse Effects and Mechanism of Environmental Endocrine Disrupting Chemicals on Female Reproductive health--the Peking University and Environment Reproductive Health Cohort
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- IVF
- Sponsor
- Peking University People's Hospital
- Enrollment
- 2000
- Locations
- 1
- Primary Endpoint
- Number of eggs retrieved
- Last Updated
- 3 years ago
Overview
Brief Summary
Infertility is a disease that seriously affects the physical and mental health of women of childbearing age. The incidence of infertility has been increasing in recent years. Studies have shown that the occurrence of infertility may be related to environmental endocrine disrupting substances. This project was designed to establish a cohort study on environmental endocrine disrupting substances and in vitro fertilization (IVF) treatment, collect blood, urine, semen, follicular fluid, granulosa cells, chorionic decidua biological specimens, and then follow up on the pregnancy outcomes. The concentration of disrupting substances was detected and then found the associations between environmental endocrine disrupting substances and female reproductive health.
Investigators
Shen Huan
Director of Reproductive Medicine Center
Peking University People's Hospital
Eligibility Criteria
Inclusion Criteria
- •Clinical diagnosis of infertile patients undergoing IVF treatment
Exclusion Criteria
- •Donor egg transplants excluded
Outcomes
Primary Outcomes
Number of eggs retrieved
Time Frame: immediately after the eggs retrieved
the number of eggs retrieved in the process of in vitro fertilization (IVF)
the miscarriage rate
Time Frame: 7 months after embryos transfer
the miscarriage rate in the process of IVF
the live birth rate
Time Frame: 40 weeks after embryos transfer
the live birth rate in the process of IVF
the number of available embryos
Time Frame: 1 week after the eggs retrieved
the number of available embryos in the process of IVF
the clinical pregnancy rate
Time Frame: 4 weeks after the embryos transfer
the clinical pregnancy rate in the process of IVF